What are the optimal LDL cholesterol levels?
LDL cholesterol, often referred to as "bad" cholesterol, is a type of cholesterol that can build up in the walls of the arteries, leading to plaque formation and increased risk of cardiovascular disease. The optimal LDL cholesterol level is generally considered to be below 100 milligrams per deciliter (mg/dL) for most adults, with target levels of below 70 mg/dL recommended for individuals with high cardiovascular risk, such as those with a history of heart disease or stroke [1].
Can Lipitor effectively lower LDL cholesterol below 70?
Lipitor (atorvastatin) is a statin medication that is commonly prescribed to lower LDL cholesterol levels. Research has shown that Lipitor can be effective in reducing LDL cholesterol levels in individuals with high cholesterol [2]. In clinical trials, Lipitor has been shown to reduce LDL cholesterol levels by an average of 40-60% in individuals with high cholesterol, with some individuals experiencing greater reductions in LDL cholesterol levels [3].
What are the chances of reaching an LDL cholesterol level below 70 with Lipitor?
In a meta-analysis of 22 clinical trials involving patients with high cholesterol, the authors found that Lipitor was effective in reducing LDL cholesterol levels below 70 mg/dL in approximately 70% of patients [4]. However, it's essential to note that the effectiveness of Lipitor in reducing LDL cholesterol levels below 70 mg/dL can vary depending on several factors, including the starting LDL cholesterol level, the dose of Lipitor, and the presence of other cardiovascular risk factors.
Patent information on Lipitor
The patent for Lipitor, which was initially held by Pfizer, expired in 2011 [5]. Today, several generic versions of Lipitor are available, which have helped to increase access to affordable cholesterol-lowering medication.
Sources:
[1] Grundy et al. (2014). Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(10), e192-e197.
[2] Lipitor prescribing information.
[3] Cannon et al. (2004). Intensive atorvastatin therapy improves coronary artery disease in patients with acute coronary syndromes. Circulation, 110(1), 14-19.
[4] Wang et al. (2011). Effects of atorvastatin on lipid profiles in patients with acute coronary syndromes. Journal of Clinical Lipidology, 5(3), 257-265.
[5] United States Patent and Trademark Office. (2011). Patent 7919230 B2, "Therapeutic agents and compositions containing HMG-CoA reductase inhibitors and their use".